Advanced search
Publication Cover
Applied Economics Volume 39, 2007 - Issue 4
Submit an article Journal homepage
501
Views
19
CrossRef citations to date
0
Altmetric
Original Articles

Pricing and patents of HIV/AIDS drugs in developing countries

Joan-Ramon Borrell University of Barcelona, Departament de Política Econòmica, Avd. Diagonal 690, 08034 Barcelona, Spain E-mail: [email protected]
Pages 505-518 | Published online: 30 Oct 2009

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

José Cuesta. (2010) How much of a threat to economic growth is a mature AIDS epidemic?. Applied Economics 42:24, pages 3077-3089.
Read now

Articles from other publishers (18)

Juana Bustamante, Christine Oughton, Vanesa Pesque-Cela & Damian Tobin. (2023) Resolving the patents paradox in the era of COVID-19 and climate change: Towards a patents taxonomy. Research Policy 52:9, pages 104850.
Crossref
Md. Deen Islam, Warren A. Kaplan, Danielle Trachtenberg, Rachel Thrasher, Kevin P. Gallagher & Veronika J. Wirtz. (2019) Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review. Globalization and Health 15:1.
Crossref
Jennifer H. Mike. (2019) A re‐evaluation of the framework for the protection of patents, women’s health in Nigeria and the issue of accessing pharmaceutical innovation in Africa: Designing strategies for medicines. The Journal of World Intellectual Property 22:3-4, pages 162-204.
Crossref
Youn Jung & Soonman Kwon. (2018) How Does Stronger Protection of Intellectual Property Rights Affect National Pharmaceutical Expenditure? An Analysis of OECD Countries. International Journal of Health Services 48:4, pages 685-701.
Crossref
Shilpi Tyagi & D.K. Nauriyal. (2017) Firm level profitability determinants in Indian drugs and pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing 11:3, pages 271-290.
Crossref
Patrick Leoni & Alvaro Sandroni. (2016) Can patent duration hinder medical innovation. International Journal of Health Economics and Management 16:4, pages 397-406.
Crossref
Jennifer Anna Sellin. (2015) Does One Size Fit All? Patents, the Right to Health and Access to Medicines. Netherlands International Law Review 62:3, pages 445-473.
Crossref
Youn Jung & Soonman Kwon. (2015) The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure. International Journal of Health Services 45:3, pages 507-529.
Crossref
Inthira Yamabhai & Richard D Smith. (2012) A review of the health and economic implications of patent protection, with a specific focus on Thailand. Health Research Policy and Systems 10:1.
Crossref
Ryan B Abbott, Rania Bader, Lina Bajjali, Taher Abu ElSamen, Thamer Obeidat, Hanan Sboul, Mustafa Shwayat & Ibrahim Alabbadi. (2012) The price of medicines in Jordan: the cost of trade-based intellectual property. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 9:2, pages 75-85.
Crossref
Walter García-FontesJoan-Ramón Borrell. 2012. Incentivos a la I+D+i de Medicamentos. Incentivos a la I+D+i de Medicamentos 93 109 .
Walter García-FontesJoan-Ramón Borrell. 2011. Incentives for Research, Development, and Innovation in Pharmaceuticals. Incentives for Research, Development, and Innovation in Pharmaceuticals 81 96 .
KIMTAEGI & Keun-Yeob Oh. (2009) The Effects of KOR-US FTA on the Patents of Korean Pharmaceutical Industry. KUKJE KYUNGJE YONGU 15:3, pages 197-223.
Crossref
Tahir AminRahul RajkumarPriti RadhakrishnanAaron S. Kesselheim. (2009) Expert Review Of Drug Patent Applications: Improving Health In The Developing World. Health Affairs 28:Supplement 1, pages w948-w956.
Crossref
Iván Moreno-Torres, Jaume Puig-Junoy & Joan-Ramon Borrell. (2007) Generic Entry into a Regulated Pharmaceutical Market. SSRN Electronic Journal.
Crossref
Patrick L. Leoni. (2014) The Economics of an HIV/AIDS Vaccine. SSRN Electronic Journal.
Crossref
Patrick L. Leoni & Alvaro Sandroni. (2011) Can Patent Duration Hinder Medical Innovation for Neglected Diseases?. SSRN Electronic Journal.
Crossref
José Cuesta. (2008) Does a Mature Aids Epidemic Threaten Growth?. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.